Sources

11 Total Sources

FDA Approves Merck's $315 Lipfendra Pill, Cutting LDL Cholesterol by Up to 60%

Left70%
Center10%
Right20%
Scientific American1d ago
FDA Approves Enlicitide (Lipfendra), New Cholesterol Pill More Powerful Than Statins
The New York Times18h ago
FDA Approves Merck's New Pill Enlicitide (Lipfendra) for Significant Cholesterol Reduction
The New York Times1d ago
FDA Approves Merck's Enlicitide Pill to Significantly Lower Cholesterol
CNN1d ago
U.S. FDA Approves Merck's Lipfendra, First Oral PCSK9 Inhibitor Cholesterol Pill
The Associated Press21h ago
FDA approves Merck's Lipfendra, a first-of-its-kind pill for high-risk cholesterol
Fox News1d ago
FDA Approves Merck's Oral PCSK9 Inhibitor Lipfendra for High Cholesterol
Reuters1d ago
Merck's cholesterol pill gets US FDA approval | Reuters
NBC News23h ago
FDA Approves Merck's Daily PCSK9 Inhibitor Pill, Lipfendra, for High Cholesterol
abcnews.com17h ago
FDA Approves Merck's Oral Pill Lipfendra for LDL Cholesterol Reduction
PhillyVoice.com1d ago
FDA Approves Merck's Daily Pill Lipfendra for Lowering LDL Cholesterol
Boston Herald1d ago
FDA Approves Merck's Lipfendra, First Noninjectable Pill for High Cholesterol